Immune Pharmaceuticals Granted Additional Time to Comply with Nasdaq Listing Requirement

NEW YORK, March 13, 2017 /PRNewswire/ — Immune Pharmaceuticals Inc. (Nasdaq: IMNP) (“Immune” or the “Company”), announced today that following a hearing on March 9, 2017, where the Company presented its plan to regain compliance including ongoing business events, the Nasdaq Hearings Panel (the “Panel”) granted the Company’s request for additional time to comply with Nasdaq…